+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Endoscopic Stricture Management Device Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 202 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5669433

Technological advancement in stricture management devices is likely to lead the growth of the market in the near future

The Global Endoscopic Stricture Management Device Market is estimated to be USD 1.22 Bn in 2023 and is expected to reach USD 1.9 Bn by 2028 growing at a CAGR of 9.21%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Endoscopic Stricture Management Device Market is segmented based on Type, Application, End User, and Geography.
  • By Type, the market is classified into Balloon Dilators, Stents and Bougie Dilators.
  • By Application, the market is classified into Esophageal and Biliary.
  • By End User, the market is classified into Hospitals and Ambulatory Surgical Centers.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Acclarent, Hebson, ARK Meditech System, Atos Medical AB, Boston Scientific Corp., CONMED Corp., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Endoscopic Stricture Management Device Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Endoscopic Stricture Management Device Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Endoscopic Stricture Management Device Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Geriatric Popuation and Rise in Prevalence of GI Disorders
4.1.2 Prefernce for Minimal Invasive Procedures
4.2 Restraints
4.2.1 Highly Expensive GI Endoscopic Procedures and Troublesome Repayment Approaches
4.3 Opportunities
4.3.1 Untapped Opportunities in Emerging Regions
New Product Launches with Advanced Technologies
4.4 Challenges
4.4.1 Lack of Trained and Skilled Healthcare Professionals in Endoscopic Stricture Technology
4.4.2 Presence of Ambiguous Regulatory Framework
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Endoscopic Stricture Management Device Market, By Type
6.1 Introduction
6.2 Balloon Dilators
6.3 Stents
6.4 Bougie Dilators
7 Global Endoscopic Stricture Management Device Market, By Application
7.1 Introduction
7.2 Esophageal
7.3 Biliary
8 Global Endoscopic Stricture Management Device Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers
9 Americas’ Endoscopic Stricture Management Device Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Endoscopic Stricture Management Device Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Endoscopic Stricture Management Device Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Endoscopic Stricture Management Device Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Acclarent
14.2 Hebson
14.3 ARK Meditech System
14.4 Atos Medical AB
14.5 Boston Scientific Corp.
14.6 CONMED Corp.
14.7 Cook
14.8 Creganna
14.9 Diversatek, Inc.
14.10 Entellus Medical, Inc.
14.11 gpcmedical.com
14.12 Hobbs Medical
14.13 isomed Edwards Lifesciences Corp.
14.14 Med pro Medical B.V.
14.15 Medtronic
14.16 Nidhi Meditech Systems.
14.17 North Coast Medical Inc.
14.18 Olympus
14.19 Qosina
14.20 Rontis Pharmaceuticals
14.21 Medi-Globe GmbH
14.22 Sumitomo Bakelite Co., Ltd.
14.23 Scanlan International
14.24 Shaili Endoscopy
14.25 Teleflex Medical CM
14.26 Therapeutic Devices, Inc.
14.27 Envaste, Ltd.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Acclarent
  • Hebson
  • ARK Meditech System
  • Atos Medical AB
  • Boston Scientific Corp.
  • CONMED Corp.
  • Cook
  • Creganna
  • Diversatek, Inc.
  • Entellus Medical, Inc.
  • gpcmedical.com
  • Hobbs Medical
  • isomed Edwards Lifesciences Corp.
  • Med pro Medical B.V.
  • Medtronic
  • Nidhi Meditech Systems.
  • North Coast Medical Inc.
  • Olympus
  • Qosina
  • Rontis Pharmaceuticals
  • Medi-Globe GmbH
  • Sumitomo Bakelite Co., Ltd.
  • Scanlan International
  • Shaili Endoscopy
  • Teleflex Medical CM
  • Therapeutic Devices, Inc.
  • Envaste, Ltd.

Table Information